Dehydrocavidine

CAS No. 83218-34-2

Dehydrocavidine ( Dehydrocorydaline )

Catalog No. M24822 CAS No. 83218-34-2

Dehydrocavidine has antitumor activity, it inhibits MCF-7 cell proliferation by inducing apoptosis mediated by regulating Bax/Bcl-2, activating caspases as well as cleaving PARP.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 419 In Stock
10MG 628 In Stock
25MG 1130 In Stock
50MG 1701 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dehydrocavidine
  • Note
    Research use only, not for human use.
  • Brief Description
    Dehydrocavidine has antitumor activity, it inhibits MCF-7 cell proliferation by inducing apoptosis mediated by regulating Bax/Bcl-2, activating caspases as well as cleaving PARP.
  • Description
    Dehydrocavidine has antitumor activity, it inhibits MCF-7 cell proliferation by inducing apoptosis mediated by regulating Bax/Bcl-2, activating caspases as well as cleaving PARP.
  • Synonyms
    Dehydrocorydaline
  • Pathway
    Angiogenesis
  • Target
    Bcl-2
  • Recptor
    Bax;Bcl-2;PARP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    83218-34-2
  • Formula Weight
    348.4
  • Molecular Formula
    C21H18NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC1=CC(C2=C(C)C(C=CC3=C4OCO3)=C4C=[N+]2C=C5)=C5C=C1OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Selective binding and highly sensitive fluorescent sensor of palmatine and dehydrocorydaline alkaloids by cucurbit[7]uril.Org Biomol Chem. 2009 Jul 7;7(13):2699-703.
molnova catalog
related products
  • Allethrin

    Allethrin induces oxidative stress, apoptosis and calcium release. Allethrin, a pyrethroid insecticide is a major mosquito repellent agent.

  • Lisaftoclax

    Bcl-2/Bcl-xl inhibitor 1 is a dual Bcl-2 and Bcl-xl inhibitor (IC50s: 2 nM and 5.9 nM for Bcl-2 and Bcl-xl) with anti-tumor activity. It is extracted from patent WO2018027097A1.

  • SW076956

    SW076956 is a small molecule that selectively disrupt Beclin 1/Bcl-2 binding as compared to Bax/Bcl-2 and Bim/Bcl-2 binding and induces autophagic flux at concentrations with minimal cytotoxicity.